Cargando…
COVID-19 adenovirus vaccine triggers antibodies against PF4 complexes to activate complement and platelets
BACKGROUND: Vaccine-induced thrombotic thrombocytopenia (VITT) is a rare coagulation disorder reported after administration of COVID-19 adenovirus-vectored vaccines. VITT is mediated by anti-platelet factor 4 (PF4) antibodies activating platelets through the Fcγ-receptor II (FcγRII), and it is assoc...
Autores principales: | Pitkänen, Hanna H., Jouppila, Annukka, Helin, Tuukka, Dulipati, Vinaya, Kotimaa, Juha, Meri, Seppo, Kantele, Anu, Jalkanen, Pinja, Julkunen, Ilkka, Lassila, Riitta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571998/ https://www.ncbi.nlm.nih.gov/pubmed/34768097 http://dx.doi.org/10.1016/j.thromres.2021.10.027 |
Ejemplares similares
-
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies
por: Solastie, Anna, et al.
Publicado: (2021) -
No evidence of autoimmunity to human OX(1) or OX(2) orexin receptors in Pandemrix-vaccinated narcoleptic children
por: Melén, Krister, et al.
Publicado: (2020) -
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs
por: Jiang, Miao, et al.
Publicado: (2023) -
Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C
por: Kohli, Shrey, et al.
Publicado: (2022) -
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination
por: Jalkanen, Pinja, et al.
Publicado: (2022)